Your email has been successfully added to our mailing list.

×
0.00869565217391308 0.0186335403726706 0.00621118012422347 0.00621118012422347 0.0198757763975155 0.0550310559006211 0.0550310559006211 0.0248447204968943
Stock impact report

Urovant Sciences to Present Late-Breaking Data on Vibegron During Plenary Session at the American Urological Association Annual Meeting

UROVANT SCIENCES LTD COMMON (UROV) 
Last urovant sciences ltd common earnings: 2/13 04:15 pm Check Earnings Report
Company Research Source: Business Wire
Second abstract with data concluding vibegron does not inhibit CYP2D6, a common drug metabolism pathway, also accepted for podium presentation IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)-- Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, today announced two vibegron abstracts were accepted for plenary and podium presentations, respectively, at the 2019 American Urological Association Annual Meeting in Chicago May 3-6, 2019. The late-breaker presentation of the vibegron international Phase 3 pivotal trial EMPOWUR by Dr. David Staskin, a principal investigator, is scheduled for the Next Frontier Plenary Session on Sunday, May 5, at 1:10 p.m. CT. A second abstract, with data concluding vibegron does not inhibit a common drug metabolism pathway will be presented by Dr. Matt Show less Read more
Impact Snapshot
Event Time:
UROV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for UROV alerts
Opt-in for
UROV alerts

from News Quantified
Opt-in for
UROV alerts

from News Quantified